Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION USP

Last updated on 2019-07-12 History
Report ID 84327
Drug Identification Number 02390582
Brand name KETOROLAC TROMETHAMINE INJECTION USP
Common or Proper name Ketorolac
Company Name PFIZER CANADA ULC
Active Ingredient(s) KETOROLAC TROMETHAMINE
Strength(s) 30MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 25 x 1 mL vial
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-08-10
Actual start date
Estimated end date 2019-09-30
Actual end date 2019-07-12
Shortage status Avoided shortage
Updated date 2019-07-12
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-07-12 French Compare
v3 2019-07-12 English Compare
v2 2019-05-17 French Compare
v1 2019-05-17 English Compare